摘要
Rhabdomyolysis(RM)is characterized by disrupting muscle cells and releasing intracellular components into circulation.Some symptoms associated with RM include muscle weakness,discolored urine,and myalgia.RM can be caused by coronavirus disease 2019(COVID-19)causing exaggerated immune response leading to muscle damage.Acute kidney injury(AKI),when presented with RM,leads to increased mortality.Examining RM-related AKI and its comparison to other AKI types in COVID-19 patients could improve the management of viral infections developing RM and AKI.RM potentially complicated COVID-19 infection course and is a major etiology of AKI.RM-related AKI had higher severity and mortality than other AKI types,with increased hypercoagulopathy and inflammatory markers.Findings also express procalcitonin use in follow-ups with severe COVID-19 patients.Study limitations include small sample size,absence of kidney biopsies,and focus on the first wave of the pandemic,which should be addressed in future research to generate accurate and relevant findings.
